All

FSMA Update: “Co-Manufacturers” Allowed Additional Time to Implement Certain Supply-Chain Program Requirements

The U.S. Food and Drug Administration (FDA) has issued a guidance, “Supply-Chain Program Requirements and Co-Manufacturer Supplier Approval and Verification for Human Food and Animal Food: Guidance for Industry,” designed to give certain co-manufacturers more…

CDC Safe Healthcare Blog: 341 Days Without a C. difficile Infection

Clostridium difficile (C. difficile or C. diff) is the most common cause of healthcare-associated diarrhea in U.S. hospitals. Reducing healthcare-acquired C. difficile infections (CDIs) is a complex and evolving battle. Check out CDC’s Safe Healthcare Blog…

Harvard’s Center for Health Law and Policy Innovation and National Viral Hepatitis Roundtable Launch Hepatitis C: State of Medicaid Access Report

Today, the Center for Health Law and Policy Innovation of Harvard Law School (CHLPI) and the National Viral Hepatitis Roundtable (NVHR) launched the Hepatitis C: State of Medicaid Access report and state report cards. The…

Interim Guidance for the Diagnosis, Evaluation, and Management of Infants with Possible Congenital Zika Virus Infection

The Centers for Disease Control and Prevention (CDC) just published guidelines to support clinicians in diagnosing, evaluating, and managing infants with possible congenital Zika virus. The revised guidance updates recommendations for the diagnosis, evaluation, and…